I'm proud of the work we're doing in Sustainable Materials at the Wyss Institute & was excited to be part of a fireside chat on this topic yesterday with Angelika Fretzen, Pam Silver, Sophie Bakalar from Collab Fund, and Noel Kinder, former Nike CSO, led by Emily Stoler.

Thanks! It was a pleasure spending time with an audience so supportive of cancer research.

Core Faculty member george church at #STATFuture today at 1:55PM. This event is bringing the pioneers who are leading the way to a new era of medicine together (virtually). statnews.com/2023/summit/fu…

This Thursday, September 7th, Dr. Rui Sun of Bayer AG will discuss how he used the Emulate Liver-Chip to better study the transduction efficiency and selectivity of liver-specific AAV promoters. Be sure to save your seat: bit.ly/44I540a #OrganChip #Webinar #GeneTherapy

Organ-on-a-Chip Technology Improves Preclinical Toxicology

Emulate, Inc. says its human Liver-Chip outperforms animal models, offering higher specificity and sensitivity in assessments of hepatotoxicity. Learn more: ow.ly/R5Eg50PFU6K

Cheering on our fruitful collaboration with the Walt Lab! This work demonstrates how microneedles coupled with Simoa technology can be used to rapidly assess melanoma treatment responses, even for rare biomarkers! Wyss Institute Don Ingber Rushdy Ahmad, PhD Natalie Artzi

We greatly enjoyed having you as part of the team!

Congratulations to Wyss Associate Faculty member Mike Springer on winning the George Ledlie Prize for developing a more streamlined coronavirus testing system used by Harvard and MIT.
news.harvard.edu/gazette/story/…

Check out this neat project by our grantee Wyss Institute 🫧

Good new drugs are rare, so bad disease models are false positive machines.
Nature Reviews Drug Discovery Consilium Scientific John A Hickman

@emmacproctor Don Ingber If you'd like to know about our current job opportunities, visit wyss.harvard.edu/careers/

Founding Director Don Ingber shares his personal path from his discovery of how living cells are constructed using “tensegrity” architecture and how this contributed to the birth of the field of Mechanobiology to his more recent work on human Organ Chips.
wyss.harvard.edu/media-post/bri…

Human organs-on-chips for disease modelling, drug development and personalized medicine go.nature.com/3Lfq997 #Review by Don Ingber Wyss Institute
Free to read here: rdcu.be/cJOud #SharedIt

We're thrilled to welcome Eli Lilly and Company as a sponsor of the #BrainTargetingProgram . They're joined by others including Alnylam Pharmaceuticals, Visterra Inc, & our sponsor & co-development partner LundbeckUS. Cell Signaling Technologies, Inc & FairJourney Biologics are also partners.

the only jobs available for people 80+ years old in america are:

- walmart greeter
- the literal president of the entire country

Curious about the new world of RNA origami and why we are so excited about it? Check out our review tandfonline.com/doi/full/10.10… Kudos to a number of excellent scientists in the field.

Congratulations Natalie Artzi for the election as a fellow of Controlled Release Society #CRS2023 Wyss Institute

Congratulations Samir!

so almost all @nature journals charge nearly $12,000 for 'gold open access' now, including the relatively new Nature Computational Science, as one of my students just learned. Outrageous to charge us at all when we do all the work 1/2

Check out this work from the Wesley Wong Lab showing a new methods they've been developing for single-molecule #proteomics that uses nanoscale devices called DNA Nanoswitch Calipers to enable them to reconstruct the 3D geometry of natively folded single-molecule complexes.